Biomea Fusion, Inc. (BMEA)
NASDAQ: BMEA · Real-Time Price · USD
1.530
-0.200 (-11.56%)
At close: Apr 28, 2026, 4:00 PM EDT
1.530
0.00 (0.00%)
After-hours: Apr 28, 2026, 6:31 PM EDT
Biomea Fusion Employees
Biomea Fusion had 41 employees as of December 31, 2025. The number of employees decreased by 65 or -61.32% compared to the previous year.
Employees
41
Change (1Y)
-65
Growth (1Y)
-61.32%
Revenue / Employee
n/a
Profits / Employee
-$1,507,244
Market Cap
110.62M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Innate Pharma | 174 |
| Verrica Pharmaceuticals | 76 |
| InflaRx | 65 |
| PepGen | 56 |
| Vivani Medical | 42 |
| Aardvark Therapeutics | 40 |
| Equillium | 35 |
| Cardiff Oncology | 31 |
BMEA News
- 10 hours ago - Biomea Fusion Transcript: Study result - Transcripts
- 1 day ago - Biomea Fusion Announces Positive 52-Week Results from Phase 2 COVALENT-112 Trial in Type 1 Diabetes Showing C-Peptide Improvement and Durability Following 12-Weeks of Icovamenib Treatment - GlobeNewsWire
- 4 weeks ago - Biomea Fusion Announces First Patient Dosed in Newly Initiated Phase II Programs Enrolling Type 2 Diabetes Patients Failing on Standard-of-Care Therapies - GlobeNewsWire
- 4 weeks ago - Biomea Fusion Transcript: Fireside chat - Transcripts
- 4 weeks ago - Biomea Fusion Transcript: Fireside chat - Transcripts
- 5 weeks ago - Biomea Fusion Reports Full Year 2025 Financial Results and Corporate Highlights - GlobeNewsWire
- 6 weeks ago - Biomea Fusion Presents Phase II COVALENT-111 Data in Type 2 Diabetes at the 19th International Conference on Advanced Technologies & Treatments for Diabetes 2026 - GlobeNewsWire
- 7 weeks ago - Biomea Fusion Transcript: The Citizens Life Sciences Conference 2026 - Transcripts